Randomized Clinical Trial of a Crataegus Oxycantha Extract in Chronic Heart Failure

NCT00343902 Phase 3 COMPLETED

To determine the effect of hawthorn extract 450 mg bid vs. placebo, in addition to standard medical therapy in ambulatory patients with NYHA class II to IV chronic heart failure on submaximal exercise as measured by the 6-minute walk test

Details

Lead sponsor	National Center for Complementary and Integrative Health (NCCIH)
Phase	Phase 3
Status	COMPLETED
Enrolment	120
Start date	2000-01
Completion	2004-05

Conditions

• Chronic Heart Failure

Interventions

• Crataegus Special Extract WS 1442

Primary outcomes

• Distance walked on a six minute walk test at six months

Countries

United States